StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report published on Tuesday. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, April 9th. Get Our Latest Stock Analysis […]
Cutter & CO Brokerage Inc. trimmed its holdings in shares of Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 9.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 117,488 shares of the company’s stock after selling 12,000 shares during the period. Cutter & CO Brokerage […]
HC Wainwright reaffirmed their buy rating on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. Separately, StockNews.com upgraded Galectin Therapeutics from a sell rating to a hold rating in a report on […]
Galectin Therapeutics (NASDAQ:GALT) Earns "Buy" Rating from HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. […]